SENSEX NIFTY

Drug Company

May 02, 2016 at 14:44 | Source: Moneycontrol.com
The company has announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
May 02, 2016 at 13:32 | Source: PTI
"The company has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Alembic Pharmaceuticals said in a BSE filing.
May 01, 2016 at 12:12 | Source: PTI
Drug major Lupin is looking to strengthen its branded and specialty business in the US by launching new products, brand acquisitions and even buyout of other specialty companies which compliment its therapy focus.
Apr 29, 2016 at 14:08 | Source: PTI
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Aurobindo Pharma said in a filing on BSE.
Apr 29, 2016 at 09:42 | Source: PTI
The company had acquired oral methylergonovine maleate (Methergine) earlier this year, Lupin said in a statement.
Apr 29, 2016 at 07:38 | Source: PTI
In a regulatory filing, Granules India said its Board of Directors today "approved further investment of USD 17.07 million (about Rs 117 crore) by way of debt/equity in Granules Pharmaceutical Inc, a wholly-owned foreign subsidiary of the company."
Apr 28, 2016 at 09:52 | Source: PTI
Citing a number of issues, including quality control, the US health regulator said it "may withhold approval of any new applications or supplements listing your firm as drug manufacturer" till corrections were made by the company which has been placed on import alert on September 11, 2015.
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Apr 26, 2016 at 15:14 | Source: PTI
NPPA has informed that during 2015-16, demand notices were issued to 263 companies amounting to Rs 928.32 crore, Minster of Chemicals & Fertilizers Ananth Kumar said in a reply in Lok Sabha.
Apr 26, 2016 at 15:04 | Source: Moneycontrol.com
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amlodipine and Valsartan Tablets USP, 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg.
Messages on Drug Company »

Wire News

Platinum Member

631 Followers

News Now  

Maintaining over 20 per cent CAGR, wellness firm Himalaya Drug Company is looking at Rs 2,500 crore revenue next fiscal and plans to hire around 1,000 people as it enters new verticals and expands distribution network.

12.52 PM Sep 25th

Wire News

Platinum Member

631 Followers

News Now  

Herbal wellness and personal care firm Himalaya Drug Company today announced foray into the mothercare segment with the launch of a range of products and is eyeing up to 6 per cent contribution in its turnover in 2 years time.

1.22 PM Sep 20th

netdo

Platinum Member

301 Followers

Larsen  

CYA for the drug companies too. I wouldn`t, however, abuse this fact! Even Asian paints, I would guess, stamps expiry dates on its paint can sooner than it really needs to be thrown out!-A Frugal saver!!!

9.23 PM Feb 1st 2013

Web Messenger

Platinum Member

368063 Followers

Pharmaceuticals - Sector  

Source:The Hindu BusinessLine - Mumbai, Jan. 31: The Himalaya Drug Company is eyeing the organic segment for personal care products in India with its Botanique brand, a readymade body care range catering to international markets. “The market for organic products is getting big in India

8.55 PM Feb 1st 2013

Web Messenger

Platinum Member

368063 Followers

AstraZeneca  

Source:BBC - Shares in AstraZeneca have fallen 4% after the drugs company announced a drop in sales and said that the tough conditions would continue. Sales in the last three months fell 16% to $7.28bn, as the firm continues to suffer an erosion of business due to the expiry of patents on its drugs

4.18 PM Feb 1st 2013

Web Messenger

Platinum Member

368063 Followers

Merck  

Source:The Hindu BusinessLine - New Delhi, Jan 30: Drug company Merck Ltd on Wednesday posted a 58.37 per cent rise in net profit at Rs 20.05 crore for the fourth quarter ended December 31, 2012 as against a net profit of Rs 12.66 crore for the same period of previous fiscal. Net sales

4.54 PM Jan 31st 2013

plunger

Silver Member

3 Followers

Granules India  

Do not average. FY14 EPS is expected to be at 12. Bulk Drug companies can be valued at a rich PE multiple of 10x. You may average only when price hits below 120. Fundamentally good but valuation-wise, still too expensive. Short to 120, if you can.

3.16 PM Jan 24th 2013

Web Messenger

Platinum Member

368063 Followers

Ajanta Pharma  

Source:Business Standard - Drug company Ajanta Pharma today reported 75.9% increase in net profit to Rs 32.57 crore for the third quarter ended December 31, 2012, mainly on robust sales. The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal.

2.48 PM Jan 24th 2013

Web Messenger

Platinum Member

368063 Followers

Ajanta Pharma  

Source:The Hindu BusinessLine - New Delhi, Jan 23: Drug company Ajanta Pharma today reported a 75.95 per cent increase in net profit at Rs 32.57 crore for the third quarter ended December 31, 2012, mainly on robust sales. The company had posted a net profit of Rs 18.51 crore in the corresponding

5.17 PM Jan 23rd 2013

Web Messenger

Platinum Member

368063 Followers

Pharmaceuticals - Sector  

Source:Economic Times - NEW DELHI: The government is all set to crack the whip on India`s shameful pharma-doctor nexus. The National Development Council (NDC), led by Prime Minister Manmohan Singh, will meet on December 27 to discuss bringing a legislation requiring drug companies to mandatorily

2.46 PM Dec 26th 2012

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.